|
|
|
|
| LEADER |
00000cam a2200000 a 4500 |
| 001 |
3304898 |
| 003 |
ICU |
| 005 |
20030526101900.0 |
| 008 |
980526s1998 nyua b 001 0 eng c |
| 010 |
|
|
|a 98026626
|
| 020 |
|
|
|a 0824701674 (alk. paper)
|
| 035 |
|
|
|a (OCoLC)39236362
|
| 040 |
|
|
|a DNLM/DLC
|c DLC
|d YDX
|d NLM
|d OCL
|d OrLoB-B
|d OCoLC
|
| 049 |
|
|
|a CGUA
|
| 050 |
0 |
0 |
|a RC591
|b .F556 1998
|
| 060 |
0 |
0 |
|a W1
|b LU62 v.120 1998
|
| 060 |
1 |
0 |
|a QU 140
|b F565 1998
|
| 069 |
0 |
|
|a 9808571
|
| 082 |
0 |
0 |
|a 616.2/38061
|2 21
|
| 245 |
0 |
0 |
|a Five-lipoxygenase products in asthma /
|c edited by Jeffrey M. Drazen, Sven-Erik Dahlén, Tak H. Lee.
|
| 246 |
3 |
|
|a 5-lipoxygenase products in asthma
|
| 260 |
|
|
|a New York :
|b M. Dekker,
|c c1998.
|
| 300 |
|
|
|a xviii, 493 p. :
|b ill. ;
|c 24 cm.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|0 http://id.loc.gov/vocabulary/contentTypes/txt
|
| 337 |
|
|
|a unmediated
|b n
|2 rdamedia
|0 http://id.loc.gov/vocabulary/mediaTypes/n
|
| 338 |
|
|
|a volume
|b nc
|2 rdacarrier
|0 http://id.loc.gov/vocabulary/carriers/nc
|
| 440 |
|
0 |
|a Lung biology in health and disease.
|v v. 120
|
| 504 |
|
|
|a Includes bibliographical references and indexes.
|
| 505 |
0 |
0 |
|t Series Introduction /
|r Claude Lenfant --
|g 1.
|t Overview of the 5-Lipoxygenase Pathway /
|r Jesper Z. Haeggstrom and Bengt Samuelsson --
|g 2.
|t 5-Lipoxygenase and 5-Lipoxygenase-Activating Protein /
|r Jilly F. Evans --
|g 3.
|t Leukotriene C[subscript 4] Synthase: A Pivotal Enzyme in the Biosynthesis of Cysteinyl Leukotrienes /
|r John F. Penrose and K. Frank Austen --
|g 4.
|t Leukotriene A[subscript 4] Hydrolase /
|r Jesper Z. Haeggstrom --
|g 5.
|t Leukotriene Export in Human Leukocytes /
|r Bing K. Lam --
|g 6.
|t Pathways of Leukotriene Metabolism in Isolated Cell Models and Human Subjects /
|r Robert C. Murphy and Pat Wheelan --
|g 7.
|t Cell Biology of the 5-Lipoxygenase Pathway: Amplification and Generation of Leukotrienes and Lipoxins by Transcellular Biosynthesis /
|r Timothy D. Bigby, Bruce D. Levy and Charles N. Serhan --
|g 8.
|t Leukotriene Receptors: Incompletely Defined Targets for Treatment of Asthma and Inflammation /
|r Sven-Erik Dahlen --
|g 9.
|t Physiological Effects of the Leukotrienes in Humans /
|r Neil C. Barnes and Lewis J. Smith --
|g 10.
|t Analysis of Leukotrienes and Lipoxins /
|r Graham W. Taylor --
|g 11.
|t Measurement of Leukotrienes from Human Biological Fluids /
|r Jay Y. Westcott and Ian K. Taylor --
|g 12.
|t Cysteinyl-Leukotriene Receptor Antagonism and 5-Lipoxygenase Inhibition in Asthma /
|r S. M. Shuaib Nasser and Tak H. Lee --
|g 13.
|t Leukotriene Receptor Antagonism and Synthesis Inhibition in Chronic Stable Asthma /
|r Elliot Israel and Jeffrey M. Drazen --
|g 14.
|t Montelukast - An Antileukotriene Treatment for Asthma: Changing the Asthma-Treatment Paradigm /
|r Beth C. Seidenberg and Theodore F. Reiss --
|g 15.
|t Pranlukast - The First Orally Active Cysteinyl Leukotriene Receptor Antagonist Marketed for the Treatment of Asthma /
|r Jeffrey W. Dubb and Anthony S. Rebuck --
|g 16.
|t Zafirlukast /
|r Catherine M. Bonuccelli and Trevor J. C. Higgins --
|g 17.
|t Zileuton: The First Leukotriene Synthesis Inhibitor for Use in the Management of Chronic Asthma /
|r Louise M. Dube, Linda J. Swanson and Walid M. Awni [et al.] --
|g 18.
|t Antileukotrienes in the Management of Asthma /
|r Paul M. O'Byrne.
|
| 650 |
|
0 |
|a Asthma
|x Pathophysiology.
|
| 650 |
|
0 |
|a Leukotrienes
|x Pathophysiology.
|
| 650 |
|
0 |
|a Leukotrienes
|x Metabolism.
|
| 650 |
|
0 |
|a Asthma
|x Chemotherapy.
|0 http://id.loc.gov/authorities/subjects/sh97008844
|
| 650 |
1 |
2 |
|a Arachidonate 5-Lipoxygenase
|x antagonists & inhibitors.
|
| 650 |
2 |
2 |
|a Arachidonate 5-Lipoxygenase
|x metabolism.
|
| 650 |
2 |
2 |
|a Receptors, Leukotriene
|x antagonists & inhibitors.
|
| 650 |
2 |
2 |
|a Leukotrienes
|x metabolism.
|
| 650 |
2 |
2 |
|a Lipoxygenase Inhibitors
|x therapeutic use.
|
| 650 |
2 |
2 |
|a Asthma
|x drug therapy.
|
| 650 |
|
7 |
|a Asthma
|x Chemotherapy.
|2 fast
|0 http://id.worldcat.org/fast/fst00819315
|
| 650 |
|
7 |
|a Asthma
|x Pathophysiology.
|2 fast
|0 http://id.worldcat.org/fast/fst00819323
|
| 700 |
1 |
|
|a Dahlén, Sven-Erik.
|0 http://id.loc.gov/authorities/names/n87833126
|1 http://viaf.org/viaf/58138631
|
| 700 |
1 |
|
|a Lee, T. H.
|q (Tak Hong)
|0 http://id.loc.gov/authorities/names/n86149323
|1 http://viaf.org/viaf/94059367
|
| 700 |
1 |
|
|a Drazen, Jeffrey M.,
|d 1946-
|0 http://id.loc.gov/authorities/names/n98801648
|1 http://viaf.org/viaf/119469009
|
| 901 |
|
|
|a ToCBNA
|
| 903 |
|
|
|a HeVa
|
| 929 |
|
|
|a cat
|
| 999 |
f |
f |
|i 348cf5b5-824c-59a8-b26d-036aa3bce547
|s 9e711f67-49a6-54c1-8a7b-566e0a1a74f3
|
| 928 |
|
|
|t Library of Congress classification
|a RC591 .F556 1998
|l ASR
|c ASR-SciASR
|i 3549532
|
| 927 |
|
|
|t Library of Congress classification
|a RC591 .F556 1998
|l ASR
|c ASR-SciASR
|e CRERAR
|b 48266719
|i 5680335
|
